Specimen Stability in Forensic Toxicology: Storage, Freeze–Thaw, and Degradation

Direct answer: a toxicology concentration is only as interpretable as the specimen history and the evidence that the analyte remained sufficiently stable under those conditions. There is no universal rule that drugs are stable merely because a sample was refrigerated or frozen. Stability can depend on the analyte, metabolite, matrix, preservative, container, temperature, storage duration, pH, bacterial activity, light exposure, and number of freeze–thaw cycles.

Forensic case review therefore should separate two questions: Was the analytical method valid? and Was the specimen itself suitable for the conclusion being drawn at the time it was analyzed? A method may be fully validated while a particular specimen has undergone pre-analytical or storage-related change.

For the collection-side analysis—specimen source, tube, preservative, transport, receipt condition, and documented temperature history—see Forensic Toxicology Specimen Collection and Preservation: Preanalytical Case Review.

Why specimen stability matters

Measured concentrations are often treated as fixed historical facts. In reality, the laboratory measures what is present in the aliquot at the time of analysis. If an analyte degrades, converts to another compound, adsorbs to a container surface, is produced by decomposition, or changes because of hydrolysis or other chemical processes, the later measurement may not be identical to the concentration present at collection.

This distinction can matter in postmortem toxicology, impaired-driving cases, drug-facilitated crime investigations, retesting, delayed analysis, and any case in which a result is close to a cutoff or another consequential numerical boundary. It also matters when two laboratories test the same nominal specimen at different times and obtain different quantitative results.

ANSI/ASB Standard 036 describes method validation as a process for demonstrating that an analytical method is fit for its intended forensic-toxicology use. Stability evidence is part of the larger reliability question because a validated instrument method cannot reverse degradation or transformation that occurred before the aliquot reached the instrument. See ANSI/ASB Standard 036 and this site’s overview of method validation in forensic toxicology.

Stability is analyte-specific, not a property of “the sample”

A frequent oversimplification is to ask whether a blood or urine sample was “stable.” The scientifically useful question is narrower: was the particular analyte or metabolite sufficiently stable in this particular matrix, under these particular storage and handling conditions, for the purpose of this interpretation?

Recent literature illustrates why broad assumptions are risky. A 2026 study of 22 sedative-type drugs and metabolites in urine found markedly different stability behavior across compounds and conditions involving pH, temperature, and repeated freezing and thawing. Some compounds remained highly stable, while others showed appreciable degradation under acidic or warmer conditions. The authors emphasized compound-specific preservation and minimizing unnecessary freeze–thaw cycles. See Journal of Analytical Toxicology, 2026.

A 2026 systematic review of pre-analytical stability of drugs of abuse in urine likewise concluded that refrigerated or frozen storage generally improved stability, but that important drug-specific exceptions remained. The review identified particular sensitivity for several analyte groups and emphasized that room-temperature storage windows can be much shorter. See Pre-analytical stability of drugs of abuse in urine for confirmatory testing.

Temperature does not answer the question by itself

“It was frozen” is not the same as “therefore the concentration was unchanged.” Freezing often slows chemical and biological processes, but the degree of protection varies. Some analytes remain stable for months under frozen conditions; others can show losses, conversions, or matrix-dependent effects even during frozen storage.

For example, long-term work on fentanyl analogs in blood showed different stability profiles among analogs and demonstrated that repeated freeze–thaw exposure could matter for some compounds. A 2023 study of synthetic cannabinoids and metabolites likewise found stability dependent on analyte, matrix, temperature, preservative, and storage duration. See Long-Term Stability of 13 Fentanyl Analogs in Blood and Evaluation of the long-term stability of synthetic cannabinoids.

Freeze–thaw cycles should be documented, not guessed

Retesting often requires thawing a primary tube or a stored aliquot. The number and duration of prior thaw events can therefore become relevant. A laboratory may have excellent freezer storage while still lacking a complete history of how many times a specimen was removed, partially thawed, aliquoted, returned to storage, transferred to another laboratory, or held during transport.

Freeze–thaw effects are not uniformly adverse. Some analytes tolerate multiple cycles under validated conditions. Others do not. A 2025 study of fentanyl analogs in brain homogenate found frozen storage favorable and reported stability through several freeze–thaw cycles for the analytes examined, while other drug classes and matrices have shown different behavior. The correct approach is therefore empirical and method-specific rather than categorical.

Example: later freeze-thaw agreement can hide a first-cycle change

A 2022 study by Gavrilovic and colleagues illustrates why the comparison point matters. The researchers fortified synthetic oral fluid with six analytes, including THC, at 100 ng/mL. This was a laboratory quality-assurance study, not a study of specimens collected from people. Aliquots were stored in glass and protected from light. The freeze-thaw experiment used freezing at -20 C, seven hours of thawing at ambient temperature, and six cycles over two weeks.

Table 7 lists THC at 100 ng/mL in the no-freeze-thaw row, 73 ng/mL after the first cycle, and 72-74 ng/mL after cycles two through six. Figure 5 shows the same pattern. Agreement among the later cycles does not mean that the first cycle left the starting material unchanged. A comparison only with the first thawed sample would answer a narrower question: how much additional change occurred afterward?

The authors considered adsorption to glass a possible explanation for the initial THC loss; the findings do not establish that every decrease was chemical degradation. Their synthetic formula included Tween 20 and sodium azide. They explicitly called for further comparison with human oral fluid. These results therefore do not establish a universal storage allowance for authentic saliva, a commercial collection device, or another laboratory’s procedure.

For a case review, ask which baseline the stability experiment used, whether it evaluated the first freeze-thaw cycle separately, and whether its matrix, container, temperature, and thawing interval match the questioned specimen. Do not use a percentage from this synthetic system to reconstruct a person’s original THC concentration, infer impairment, or automatically invalidate a result.

Source: Gavrilovic et al., Stability of drugs of abuse in synthetic oral fluid investigated using a simple "dilute and inject" method of analysis. Drug Testing and Analysis. 2022;14:1482-1490. DOI: 10.1002/dta.3279. See Table 7 and Figure 5.

Added October 3, 2026. This section was prepared with AI assistance after review of the full nine-page paper, including its tables, figures, and references. Personal review by Okorie Okorocha has not been confirmed.

Preservatives, pH, container material, and matrix can change the result

Storage temperature is only one part of the pre-analytical history. Sodium fluoride and other preservatives may suppress some processes but do not guarantee universal stability. Urine pH can influence degradation pathways. Whole blood, serum, plasma, urine, vitreous, tissue homogenate, and dried blood spots can behave differently. Container composition can also matter when compounds adsorb to surfaces or when headspace, light, or evaporation becomes relevant.

This is why stability evidence should be matched as closely as possible to the actual case conditions: same analyte, relevant concentration range, same matrix, comparable preservative, realistic container, similar temperature, and a storage interval that covers the case timeline. Extrapolating from a different matrix or a short validation experiment to years of storage may exceed what the data establish.

Related examples on this site include 7-hydroxymitragynine stability in plasma and nitazene stability in dried blood spots, both of which illustrate why compound- and matrix-specific data should not be generalized beyond their experimental conditions.

What degradation can do to forensic interpretation

Degradation does not automatically invalidate a result. Its significance depends on the forensic question. For qualitative identification, modest quantitative loss may not alter the conclusion that an analyte was present. For quantitative interpretation, however, degradation can affect comparisons with therapeutic, toxic, fatal, statutory, or laboratory reporting thresholds. Formation of a metabolite or degradation product can also complicate interpretation if the transformation mimics biological metabolism.

The same reasoning applies to repeat testing. A lower concentration on reanalysis does not necessarily prove that the original analysis was wrong; a higher concentration does not necessarily prove that the later analysis is superior. The comparison requires consideration of analytical precision, aliquot differences, homogeneity, storage, stability, and uncertainty. When aliquot differences are material, review specimen homogeneity and aliquot representativeness separately from chemical stability. See Repeat Analysis and Replicate Agreement in Forensic Toxicology.

Case-review questions for specimen stability

A defensible review should identify the collection date and time; specimen type and anatomical source; tube or container; preservative and anticoagulant; temperature during transport; time before refrigeration or freezing; long-term storage temperature; any known freezer excursions; aliquoting history; number of freeze–thaw events; date of first analysis; date of reanalysis; and whether the laboratory has analyte- and matrix-specific stability data covering the relevant interval. The review should separately ask whether the extracted sample remained within the laboratory’s validated hold time; see Autosampler Stability in Forensic Toxicology for processed-sample and reinjection issues.

It is also useful to determine whether stability studies were performed at concentrations similar to the case result and whether acceptance criteria were pre-specified. A stability study demonstrating acceptable performance at high concentration does not automatically establish equivalent behavior near the lower limit of quantitation or a reporting cutoff.

Stability near a cutoff or decision point

Results close to a cutoff require particular care because analytical uncertainty and pre-analytical change can operate at the same time. The laboratory’s validated measurement uncertainty does not ordinarily include every possible historical storage effect in an individual specimen. A reviewer should therefore avoid using a generic uncertainty interval as if it automatically corrects for degradation.

For a broader discussion of numerical decision points, see Measurement Uncertainty Near Forensic Toxicology Cutoffs and Measurement Uncertainty in Forensic Toxicology.

Can a frozen forensic specimen be assumed stable?

No. Frozen storage is often preferable to warmer storage, but stability remains compound-, matrix-, temperature-, duration-, and handling-dependent. The appropriate support is empirical stability evidence that reasonably matches the case conditions.

Does one freeze–thaw cycle invalidate a toxicology result?

Not by itself. Many analytes are stable through one or more cycles under studied conditions. The question is whether the specific analyte and matrix have adequate supporting data and whether the case specimen’s handling history is known.

Can retesting years later be compared directly with the original result?

Sometimes, but not automatically. A direct comparison should account for long-term stability, storage temperature, preservatives, container, freeze–thaw history, specimen homogeneity, analytical method differences, and measurement uncertainty. The longer the interval, the more important it is to identify data that actually cover the relevant storage duration.

Bottom line

Specimen stability is a scientific boundary condition on toxicology interpretation, not an administrative detail. The strongest conclusion is the one supported by the actual analyte, matrix, storage history, validation data, and published evidence. “Refrigerated,” “frozen,” or “preserved” should begin the stability inquiry—not end it.